Summary
BioSight, a privately-held pharmaceutical company developing innovative therapeutics for hematological malignancies and disorders.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Ruth Ben Yakar
CEO
Roy Golan
CFO
Pini Orbach
Chairman
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy